MAPT and neuroblastoma: Having identified this signature under normal cell cycle conditions in a neuroblastoma cell line, we assessed its generality and robustness in vitro, by extending our analysis to (i) a distinct cell line: HeLa cells stably expressing the 0N4R Tau construct [42], (ii) an alternative technique: Western blot analysis, which required cell cycle synchronization.